BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27861791)

  • 1. FOXP1 is a regulator of quiescence in healthy human CD4
    Garaud S; Roufosse F; De Silva P; Gu-Trantien C; Lodewyckx JN; Duvillier H; Dedeurwaerder S; Bizet M; Defrance M; Fuks F; Bex F; Willard-Gallo K
    Eur J Immunol; 2017 Jan; 47(1):168-179. PubMed ID: 27861791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The artificial loss of Runx1 reduces the expression of quiescence-associated transcription factors in CD4(+) T lymphocytes.
    Wong WF; Kohu K; Nagashima T; Funayama R; Matsumoto M; Movahed E; Tan GM; Yeow TC; Looi CY; Kurokawa M; Osato M; Igarashi K; Nakayama K; Satake M
    Mol Immunol; 2015 Dec; 68(2 Pt A):223-33. PubMed ID: 26350416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells.
    van Keimpema M; Grüneberg LJ; Schilder-Tol EJ; Oud ME; Beuling EA; Hensbergen PJ; de Jong J; Pals ST; Spaargaren M
    Haematologica; 2017 Mar; 102(3):573-583. PubMed ID: 27909217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma.
    Ackermann S; Kocak H; Hero B; Ehemann V; Kahlert Y; Oberthuer A; Roels F; Theißen J; Odenthal M; Berthold F; Fischer M
    BMC Cancer; 2014 Nov; 14():840. PubMed ID: 25406647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4
    Batorov EV; Tikhonova MA; Kryuchkova IV; Sergeevicheva VV; Sizikova SA; Ushakova GY; Batorova DS; Gilevich AV; Ostanin AA; Shevela EY; Chernykh ER
    Int J Hematol; 2017 Jul; 106(1):108-115. PubMed ID: 28293817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-7R alpha gene expression is inversely correlated with cell cycle progression in IL-7-stimulated T lymphocytes.
    Swainson L; Verhoeyen E; Cosset FL; Taylor N
    J Immunol; 2006 Jun; 176(11):6702-8. PubMed ID: 16709829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of T
    Bi E; Ma X; Lu Y; Yang M; Wang Q; Xue G; Qian J; Wang S; Yi Q
    Sci Signal; 2017 Oct; 10(500):. PubMed ID: 29018172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells.
    Brown PJ; Gascoyne DM; Lyne L; Spearman H; Felce SL; McFadden N; Chakravarty P; Barrans S; Lynham S; Calado DP; Ward M; Banham AH
    Haematologica; 2016 Jul; 101(7):861-71. PubMed ID: 27056922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte integrin signaling regulates FOXP1 gene expression via FOXP1-IT1 long non-coding RNA-mediated IRAK1 pathway.
    Shi C; Miley J; Nottingham A; Morooka T; Prosdocimo DA; Simon DI
    Biochim Biophys Acta Gene Regul Mech; 2019 Apr; 1862(4):493-508. PubMed ID: 30831269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells.
    Feng X; Wang H; Takata H; Day TJ; Willen J; Hu H
    Nat Immunol; 2011 Jun; 12(6):544-50. PubMed ID: 21532575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neglected, yet significant role of FOXP1 in T-cell quiescence, differentiation and exhaustion.
    Kaminskiy Y; Kuznetsova V; Kudriaeva A; Zmievskaya E; Bulatov E
    Front Immunol; 2022; 13():971045. PubMed ID: 36268015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blimp-1, an intrinsic factor that represses HIV-1 proviral transcription in memory CD4+ T cells.
    Kaczmarek Michaels K; Natarajan M; Euler Z; Alter G; Viglianti G; Henderson AJ
    J Immunol; 2015 Apr; 194(7):3267-74. PubMed ID: 25710909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting and Activated Natural Tregs Decrease in the Peripheral Blood of Patients with Atherosclerosis.
    Yazdani M; Khosropanah S; Hosseini A; Doroudchi M
    Iran J Immunol; 2016 Dec; 13(4):249-262. PubMed ID: 27999237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulated expression of the TPβ isoform of the human T prostanoid receptor by the tumour suppressors FOXP1 and NKX3.1: Implications for the role of thromboxane in prostate cancer.
    O'Sullivan AG; Eivers SB; Mulvaney EP; Kinsella BT
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3153-3169. PubMed ID: 28890397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting Edge: Foxp1 Controls Naive CD8+ T Cell Quiescence by Simultaneously Repressing Key Pathways in Cellular Metabolism and Cell Cycle Progression.
    Wei H; Geng J; Shi B; Liu Z; Wang YH; Stevens AC; Sprout SL; Yao M; Wang H; Hu H
    J Immunol; 2016 May; 196(9):3537-41. PubMed ID: 27001958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demethylation of the RORC2 and IL17A in human CD4+ T lymphocytes defines Th17 origin of nonclassic Th1 cells.
    Mazzoni A; Santarlasci V; Maggi L; Capone M; Rossi MC; Querci V; De Palma R; Chang HD; Thiel A; Cimaz R; Liotta F; Cosmi L; Maggi E; Radbruch A; Romagnani S; Dong J; Annunziato F
    J Immunol; 2015 Apr; 194(7):3116-26. PubMed ID: 25740946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The forkhead transcription factor FOXP1 represses human plasma cell differentiation.
    van Keimpema M; Grüneberg LJ; Mokry M; van Boxtel R; van Zelm MC; Coffer P; Pals ST; Spaargaren M
    Blood; 2015 Oct; 126(18):2098-109. PubMed ID: 26289642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement receptor type 1 (CR1/CD35) expressed on activated human CD4+ T cells contributes to generation of regulatory T cells.
    Török K; Dezső B; Bencsik A; Uzonyi B; Erdei A
    Immunol Lett; 2015 Apr; 164(2):117-24. PubMed ID: 25742728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factor Foxp1 is a critical negative regulator of the differentiation of follicular helper T cells.
    Wang H; Geng J; Wen X; Bi E; Kossenkov AV; Wolf AI; Tas J; Choi YS; Takata H; Day TJ; Chang LY; Sprout SL; Becker EK; Willen J; Tian L; Wang X; Xiao C; Jiang P; Crotty S; Victora GD; Showe LC; Tucker HO; Erikson J; Hu H
    Nat Immunol; 2014 Jul; 15(7):667-75. PubMed ID: 24859450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor β-mediated suppression of antitumor T cells requires FoxP1 transcription factor expression.
    Stephen TL; Rutkowski MR; Allegrezza MJ; Perales-Puchalt A; Tesone AJ; Svoronos N; Nguyen JM; Sarmin F; Borowsky ME; Tchou J; Conejo-Garcia JR
    Immunity; 2014 Sep; 41(3):427-439. PubMed ID: 25238097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.